Welcome!

News Feed Item

Everyday Health Reports Second Quarter 2014 Financial Results

NEW YORK, Aug. 11, 2014 /PRNewswire/ -- Everyday Health, Inc. (NYSE: EVDY), a leading digital health and wellness company, today announced financial results for the second quarter ended June 30, 2014.  

Everyday Health, Inc. Logo.
  • Advertising and sponsorship revenue grew 16% year-over-year.
  • Average revenue per advertiser increased 39% year-over-year.
  • Mobile revenue grew 60% year-over-year.
  • Adjusted EBITDA grew 72% year-over-year.
  • Non-GAAP EPS was $0.07.

"We are extremely pleased with our performance in the second quarter of 2014, as we continue to provide market-leading solutions and real results for our customers, consumers, and healthcare professionals," said Ben Wolin, Co-Founder and CEO of Everyday Health. "Our new consumer and professional partnerships with influential constituents across the healthcare ecosystem further validate our unique business model and will strengthen our leadership position in the marketplace."

Financial Highlights

For the three months ended June 30, 2014:

  • Total revenue was $41.4 million, an 11% increase from $37.2 million in the prior year period. 
    • Advertising and sponsorship revenue was $36.9 million, a 16% increase from $31.8 million in the prior year period.
    • Premium services revenue was $4.6 million, a 15% decrease from $5.4 million in the prior year period, consistent with the Company's strategy of focusing on advertising and sponsorship revenue.
  • Adjusted EBITDA was $6.9 million, a 72% increase from $4.0 million in the prior year period.
  • Net income on a non-GAAP basis was $2.4 million, compared to a loss of ($2.9) million in the prior year period. Earnings per share on a non-GAAP diluted basis was $0.07. Net loss on a GAAP basis was ($0.6) million, before the impact of the non-cash, one-time deemed dividend of $8.1 million associated with the conversion of the Company's Series G preferred stock at the time of its initial public offering, compared to a net loss of ($6.2) million in the prior year period. Net loss per share on a GAAP basis was ($0.02) before the Series G deemed dividend, or ($0.29) including the impact of the Series G deemed dividend. A description of the non-GAAP calculations and reconciliation to comparable GAAP measures is provided in the accompanying tables entitled "Adjusted EBITDA Reconciliation" and "Reconciliation of Non-GAAP Net Income (Loss)."

"Our continued ability to deliver profitable growth validates the success of our strategy to go deeper with our existing customers and to leverage our partnership business model," said Brian Cooper, CFO of Everyday Health. "We are pleased with our performance and excited about our opportunity in the second half of 2014."

Business Highlights

The Company has also entered into several key business partnerships across its consumer and professional businesses, including the following:

  • An extension of the Company's long-standing relationship with Mayo Clinic, through which the Company will deliver Mayo Clinic's educational content, resources, and tools on MedPage Today.
  • The "Diabetes Step-by-Step" initiative, a highly engaging multimedia consumer resource for diabetes education and support, which will feature Randy Jackson, the popular television personality and diabetes advocate.
  • A partnership with the American Society of Clinical Oncology ("ASCO") to provide editorial coverage of ASCO's numerous conferences and a digital channel to communicate directly with their physicians. With this partnership, Everyday Health will reach approximately 90% of all oncologists and hematologists in the U.S.
  • A collaboration with SERMO, the leading social network for physicians, to provide MedPage Today content to the SERMO physician audience and to offer MedPage Today's custom marketing programs on the SERMO network.

Financial Outlook

For the third quarter of 2014 and full year 2014, the Company anticipates achieving financial results as set forth below:

Third Quarter of 2014



Total Revenue

$41.4 million – $42.2 million


Advertising & Sponsorship Revenue

$37.0 million – $37.8 million


Adjusted EBITDA

$6.75 million – $6.85 million




Full Year 2014



Total Revenue

$180.2 million – $181.8 million


Advertising & Sponsorship Revenue

$162.0 million – $164.0 million


Adjusted EBITDA

$34.2 million – $34.7 million

Earnings Teleconference Information

The Company will discuss its second quarter 2014 financial results and business outlook during a teleconference today, August 11, 2014, at 5:00 PM ET.  The conference call can be accessed at (877) 201-0168 or (647) 788-4901 (International), conference ID# 76415896. The call will also be broadcast simultaneously at http://ir.everydayhealth.com.

Following completion of the call, a recorded replay of the webcast will be available on Everyday Health's website.  To listen to the telephone replay, call toll-free (855) 859-2056 or (404) 537-3406 (International), conference ID# 76415896. The telephone replay will be available from 8:00 PM ET August 11 through 11:59 PM ET August 17, 2014. Additional investor information can be accessed at http://ir.everydayhealth.com.

About Everyday Health, Inc.  

Everyday Health, Inc. (NYSE: EVDY) is a leading provider of digital health and wellness solutions. Everyday Health attracts a large and engaged audience of consumers and healthcare professionals to its premier health and wellness properties, and utilizes its data and analytics expertise to deliver highly personalized content experiences and efficient and effective marketing and engagement solutions. Everyday Health enables consumers to manage their daily health and wellness needs, healthcare professionals to stay informed and make better decisions for their patients, and marketers, health payors and providers to communicate and engage with consumers and healthcare professionals to drive better health outcomes. Everyday Health's content and solutions are delivered through multiple channels, including desktop, mobile web, and mobile phone and tablet applications, as well as video and social media.

Safe Harbor Provision

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by their use of terms and phrases such as "anticipate," "enable," "expect," "will," "believe," "continue" and other similar terms and phrases, and such forward-looking statements include, but are not limited to, the statements regarding our future financial performance set forth under the heading "Financial Outlook." The outcome of the events described in these forward-looking statements is subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated by these forward-looking statements, including, but not limited to: our ability to attract and retain users to our portfolio of properties; our ability to attract and retain customers; the timing and amount of advertising spending by our current and future customers; our ability to enter into new, or extend existing, partnership arrangements; our ability to successfully pursue opportunities in the broader health and wellness sectors; as well as those factors contained in the "Risk Factors" section of our Quarterly Report on Form 10-Q for the quarter ended March 31, 2014 filed with the SEC on May 13, 2014 and our other SEC filings. All information in this release is as of August 11, 2014. Except as required by law, we undertake no obligation to update publicly any forward-looking statement made herein for any reason to conform the statement to actual results or changes in our expectations.

Use of Non-GAAP Financial Measures

To supplement the financial measures presented in the Company's press release and related conference call or webcast in accordance with accounting principles generally accepted in the United States ("GAAP"), we also present the following non-GAAP measures of financial performance: Adjusted EBITDA, non-GAAP net income (loss) and non-GAAP earnings per share ("EPS").

A "non-GAAP financial measure" refers to a numerical measure of the Company's historical or future financial performance, financial position, or cash flows that excludes (or includes) amounts that are included in (or excluded from) the most directly comparable measure calculated and presented in accordance with GAAP in the Company's financial statements. The Company provides certain non-GAAP measures as additional information relating to its operating results as a complement to results provided in accordance with GAAP. The non-GAAP financial information presented here should be considered in conjunction with, and not as a substitute for or superior to, the financial information presented in accordance with GAAP and should not be considered a measure of the Company's liquidity. There are significant limitations associated with the use of non-GAAP financial measures. Further, these measures may differ from the non-GAAP information, even where similarly titled, used by other companies and therefore should not be used to compare the Company's performance to that of other companies.

The Company has presented Adjusted EBITDA, non-GAAP net income (loss) and non-GAAP EPS as non-GAAP financial measures in this press release. We define Adjusted EBITDA as net loss plus: interest expense, net; income tax expense; depreciation and amortization expense; stock-based compensation expense; compensation expense related to acquisition earnout arrangements; write-offs of unamortized deferred financing and other debt extinguishment costs; reduction in force severance charges; loss from discontinued operations; and certain other non-cash charges such as preferred stock warrant mark-to-market adjustments. We define non-GAAP net income (loss) as net loss, plus non-cash stock-based compensation, non-cash deemed dividend on the Series G IPO ratchet, compensation expense related to acquisition earnout arrangements, loss from discontinued operations, and other unusual or significant adjustments such as the write-off of deferred finance costs and other debt extinguishment costs and the preferred stock mark-to-market adjustment. We define non-GAAP EPS as non-GAAP net income (loss) divided by weighted-average shares outstanding, which reflects the issuance of the shares sold in the IPO, as well as the conversion of all outstanding shares of preferred stock into common stock in connection with the Company's IPO, which closed on April 2, 2014.

The Company believes the use of non-GAAP financial measures, as a supplement to GAAP measures, is useful to investors in that they eliminate items that are either not part of the Company's core operations or do not require a cash outlay, such as stock-based compensation. Our management uses these non-GAAP financial measures when evaluating the Company's operating performance and for internal planning and forecasting purposes. The Company believes that these non-GAAP financial measures help indicate underlying trends in the Company's business, are important in comparing current results with prior period results, and are useful to investors and financial analysts in assessing the Company's operating performance.

 

EVERYDAY HEALTH, INC.


Consolidated Balance Sheets


(in thousands, except share and per share data)










June 30,
2014
 (unaudited)


December 31,
2013



Assets








Current assets:








Cash and cash equivalents


$

55,084


$

16,242


Accounts receivable, net of allowance for doubtful accounts of $487 and $530 as of June 30, 2014 and December 31, 2013, respectively



39,635



49,373


Deferred tax asset



133



133


Prepaid expenses and other current assets



7,193



7,822


Total current assets



102,045



73,570


Property and equipment, net



22,839



21,095


Goodwill



82,153



82,153


Intangible assets, net



8,644



9,735


Other assets



4,806



5,729


Total assets


$

220,487


$

192,282










Liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)








Current liabilities:








Accounts payable


$

7,108


$

8,459


Accrued expenses



14,609



25,919


Deferred revenue



8,156



6,808


Current portion of long-term debt



2,000



1,333


Other current liabilities



854



830


Total current liabilities



32,727



43,349


Long-term debt



38,000



70,000


Deferred tax liabilities



5,680



5,199


Other long-term liabilities



4,340



4,937


Redeemable convertible preferred stock (Series A-G), net of expenses, $0.01 par value: 10,000,000 and 27,204,144 shares authorized at June 30, 2014 and December 31, 2013, respectively; no shares and 26,820,270 shares issued and outstanding at  June 30, 2014 and December 31, 2013, respectively



-



158,766


Stockholders' equity (deficit):








Common stock, $0.01 par value: 90,000,000 and 45,000,000 shares authorized at June 30, 2014 and December 31, 2013, respectively; 30,185,974 and 5,366,478 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively



302



54


Treasury stock



(55)



(55)


Additional paid-in capital



279,620



33,726


Accumulated deficit



(140,127)



(123,694)


Total stockholders' equity (deficit)



139,740



(89,969)


Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)


$

220,487


$

192,282


 

EVERYDAY HEALTH, INC.

Consolidated Statements of Operations

(in thousands, except share and per share data, unaudited)
















Three months ended June 30,


Six months ended June 30,



2014


2013


2014


2013

Revenues













Advertising and sponsorship revenues 


$

36,882


$

31,819


$

69,574


$

57,199

Premium services revenues 



4,565



5,379



9,378



10,503

Total revenues 



41,447



37,198



78,952



67,702

Operating expenses:













Cost of revenues



10,961



10,826



22,382



20,661

Sales and marketing



13,069



11,860



24,039



20,921

Product development



9,952



10,700



19,964



20,860

General and administrative



7,126



6,191



13,721



12,730

Total operating expenses



41,108



39,577



80,106



75,172

Income (loss) from operations



339



(2,379)



(1,154)



(7,470)

Interest expense, net



(585)



(2,015)



(2,448)



(4,144)

Other expense



-



-



(4,114)



-

Loss from continuing operations before provision for income taxes 



(246)



(4,394)



(7,716)



(11,614)

Provision for income taxes 



(349)



(247)



(638)



(511)

Loss from continuing operations



(595)



(4,641)



(8,354)



(12,125)

Loss from discontinued operations, net of tax



-



(1,596)



-



(3,341)

Net loss



(595)



(6,237)



(8,354)



(15,466)

Series G preferred stock deemed dividend



(8,079)



-



(8,079)



-

Net loss attributable to common stockholders


$

(8,674)


$

(6,237)


$

(16,433)


$

(15,466)














Net loss from continuing operations per share—basic and diluted


$

(0.02)


$

(0.92)


$

(0.47)


$

(2.44)

Net loss from discontinued operations per share—basic and diluted


$

-


$

(0.32)


$

-


$

(0.67)














Net loss per share—basic and diluted


$

(0.02)


$

(1.24)


$

(0.47)


$

(3.11)














Net loss attributable to common stockholders per share—basic and diluted


$

(0.29)


$

(1.24)


$

(0.93)


$

(3.11)














Weighted-average common shares outstanding—basic and diluted



29,802,970



5,030,265



17,670,809



4,978,075

 










EVERYDAY HEALTH, INC.


Consolidated Statements of Cash Flows


(in thousands, unaudited)




Six months ended June 30,



2014


2013

Cash flows from operating activities








Net loss 


$

(8,354)


$

(15,466)


Less loss from discontinued operations, net of tax 



-



3,341


Loss from continuing operations 



(8,354)



(12,125)


Adjustments to reconcile loss from continuing operations to net cash provided
   by operating activities:








Depreciation and amortization 



7,150



7,817


Amortization of video and television costs 



-



449


Provision for doubtful accounts 



215



62


Stock-based compensation 



4,019



969


Amortization and write-off of financing costs 



4,239



823


Loss on disposals of property and equipment



-



147


Provision for deferred income taxes 



481



481


Changes in operating assets and liabilities:








Accounts receivable 



9,522



5,741


Prepaid expenses and other current assets 



(456)



(334)


Additions to video and television costs  



-



(423)


Accounts payable and accrued expenses 



(11,740)



(1,333)


Deferred revenue 



1,347



1,943


Other current liabilities 



(103)



(331)


Other long-term liabilities 



618



631


Net cash provided by operating activities from continuing operations 



6,938



4,517


Net cash used in operating activities from discontinued operations 



-



(3,504)


Net cash provided by operating activities 



6,938



1,013


Cash flows from investing activities








Additions to property and equipment, net 



(7,441)



(5,438)


Proceeds from sale of business 



400



-


Payment for business purchased, net of cash acquired 



-



(4,304)


Payment of security deposits and other assets 



47



(755)


Net cash used in investing activities 



(6,994)



(10,497)


Cash flows from financing activities








Net proceeds from common stock issuance



70,622



-


Proceeds from the exercise of stock options 



2,151



31


Repayments of principal under former revolver credit facility



(30,000)



(400)


Repayment of principal under former term loan facility 



(41,333)



(1,417)


Borrowings under revolver credit facility



32,300



-


Repayment of principal under revolver credit facility



(32,300)



-


Borrowings under term loan facility 



40,000



-


Principal payments on capital lease obligations 



(308)



(156)


Payments of credit facility financing costs 



(2,234)



-


Payment for purchase of treasury stock 



-



(55)


Net cash provided by (used in) financing activities



38,898



(1,997)


Net decrease in cash and cash equivalents 



38,842



(11,481)


Cash and cash equivalents, beginning of period



16,242



23,888


Cash and cash equivalents, end of period


$

55,084


$

12,407


Supplemental disclosure of cash flow information








Interest paid 


$

2,867


$

3,229


Income taxes paid 


$

163


$

37


Supplemental disclosure of non-cash investing and financing activities








Issuance of common stock for acquired business 


$

919


$

1,814


Issuance of common stock for acquired assets


$

-


$

74


Warrants issued in connection with website partner agreement


$

1,131


$

-


Capital lease obligations incurred


$

362


$

344


Reclassification of liability warrants to equity warrants


$

1,140


$

-









 















EVERYDAY HEALTH, INC.


Adjusted EBITDA Reconciliation


(in thousands, unaudited)
















Three months ended June 30,


Six months ended June 30,



2014



2013



2014



2013

Adjusted EBITDA

$

6,932


$

4,030


$

10,149


$

4,196















       Interest Expense, net


585



2,015



2,448



4,144


       Income tax provision


349



247



638



511


       Depreciation and amortization expense


3,592



3,897



7,150



7,817


       Stock compensation expense


2,950



517



4,019



969


       Compensation expense related to acquisition earnout


51



1,175



135



1,375


       Write-off of debt extinguishment costs


-



-



3,861



-


       Reduction in force severance charges


-



673



-



1,358


       Preferred stock warrant mark-to-market adjustment


-



-



252



-


       Asset impairment charges


-



147



-



147


       Loss from discontinued operations


-



1,596



-



3,341


Net loss

$

(595)


$

(6,237)


$

(8,354)


$

(15,466)















       Deemed Dividend on Series G Ratchet Provision


8,079



-



8,079



-


Net loss attributable to common stockholders

$

(8,674)


$

(6,237)


$

(16,433)


$

(15,466)














 















EVERYDAY HEALTH, INC.


Reconciliation of Non-GAAP Net Income (Loss)


(in thousands, except share and per share data, unaudited)

















Three months ended June 30,



Six months ended June 30,



2014



2013



2014



2013


Net loss attributable to common stockholders

$

(8,674)


$

(6,237)


$

(16,433)


$

(15,466)















       Deemed Dividend on Series G Ratchet Provision


8,079



-



8,079



-


       Stock compensation expense


2,950



517



4,019



969


       Write-off of debt extinguishment costs


-



-



3,861



-


       Preferred stock warrant mark-to-market adjustment


-



-



252



-


       Compensation expense related to acquisition earnout


51



1,175



135



1,375


       Loss from discontinued operations


-



1,596



-



3,341















Non-GAAP net income (loss)

$

2,406


$

(2,949)


$

(87)


$

(9,781)















Weighted-average common shares outstanding—basic


29,802,970



5,030,265



17,670,809



4,978,075


Weighted-average common shares outstanding—diluted


32,663,419



5,030,265



17,670,809



4,978,075















Non-GAAP net income (loss) per common share—basic

$

0.08


$

(0.59)


$

(0.00)


$

(1.96)


Non-GAAP net income (loss) per common share—diluted

$

0.07


$

(0.59)


$

(0.00)


$

(1.96)



























 

Logo - http://photos.prnewswire.com/prnh/20101112/NY00568LOGO

SOURCE Everyday Health, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Tappest will exhibit MooseFS at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. MooseFS is a breakthrough concept in the storage industry. It allows you to secure stored data with either duplication or erasure coding using any server. The newest – 4.0 version of the software enables users to maintain the redundancy level with even 50% less hard drive space required. The software func...
SYS-CON Events announced today that EARP will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. "We are a software house, so we perfectly understand challenges that other software houses face in their projects. We can augment a team, that will work with the same standards and processes as our partners' internal teams. Our teams will deliver the same quality within the required time and budget just as our partn...
SYS-CON Events announced today that Interoute, owner-operator of one of Europe's largest networks and a global cloud services platform, has been named “Bronze Sponsor” of SYS-CON's 20th Cloud Expo, which will take place on June 6-8, 2017 at the Javits Center in New York, New York. Interoute is the owner-operator of one of Europe's largest networks and a global cloud services platform which encompasses 12 data centers, 14 virtual data centers and 31 colocation centers, with connections to 195 add...
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software in the hope of capturing value in IoT. Although IoT is relatively new in the market, it has already gone through many promotional terms such as IoE, IoX, SDX, Edge/Fog, Mist Compute, etc. Ultimately, irrespective of the name, it is about deriving value from independent software assets participating in an ecosystem as one comprehensive solution.
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @ThingsExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
Amazon started as an online bookseller 20 years ago. Since then, it has evolved into a technology juggernaut that has disrupted multiple markets and industries and touches many aspects of our lives. It is a relentless technology and business model innovator driving disruption throughout numerous ecosystems. Amazon’s AWS revenues alone are approaching $16B a year making it one of the largest IT companies in the world. With dominant offerings in Cloud, IoT, eCommerce, Big Data, AI, Digital Assista...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
SYS-CON Events announced today that Systena America will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Systena Group has been in business for various software development and verification in Japan, US, ASEAN, and China by utilizing the knowledge we gained from all types of device development for various industries including smartphones (Android/iOS), wireless communication, security technology and IoT serv...
SYS-CON Events announced today that Outscale will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Outscale's technology makes an automated and adaptable Cloud available to businesses, supporting them in the most complex IT projects while controlling their operational aspects. You boost your IT infrastructure's reactivity, with request responses that only take a few seconds.
Everywhere we turn in our industry we can find strong opinions about the direction, type and nature of cloud’s impact on computing and business. Another word that is used in every context in our industry is “hybrid.” In his session at 20th Cloud Expo, Alvaro Gonzalez, Director of Technical, Partner and Field Marketing at Peak 10, will use a combination of a few conceptual props and some research recently commissioned by Peak 10 to offer a real-world consideration of how the various categories of...
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
DevOps at Cloud Expo – being held October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's largest enterprises – and delivering real r...
Cloud applications are seeing a deluge of requests to support the exploding advanced analytics market. “Open analytics” is the emerging strategy to deliver that data through an open data access layer, in the cloud, to be directly consumed by external analytics tools and popular programming languages. An increasing number of data engineers and data scientists use a variety of platforms and advanced analytics languages such as SAS, R, Python and Java, as well as frameworks such as Hadoop and Spark...
Cloud promises the agility required by today’s digital businesses. As organizations adopt cloud based infrastructures and services, their IT resources become increasingly dynamic and hybrid in nature. Managing these require modern IT operations and tools. In his session at 20th Cloud Expo, Raj Sundaram, Senior Principal Product Manager at CA Technologies, will discuss how to modernize your IT operations in order to proactively manage your hybrid cloud and IT environments. He will be sharing bes...
Five years ago development was seen as a dead-end career, now it’s anything but – with an explosion in mobile and IoT initiatives increasing the demand for skilled engineers. But apart from having a ready supply of great coders, what constitutes true ‘DevOps Royalty’? It’ll be the ability to craft resilient architectures, supportability, security everywhere across the software lifecycle. In his keynote at @DevOpsSummit at 20th Cloud Expo, Jeffrey Scheaffer, GM and SVP, Continuous Delivery Busine...